Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for post-COVID-19 loss of smell
ISRCTN70794078Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Olfactory disorder and post-COVID syndrome comparing Prednisolone + smell training with Placebo + smell training (2 arms). Primary endpoint: Objective olfactory function. Started Oct 2021; status: completed.
02
Drugs
prednisolone
03
Conditions
Olfactory disorderpost-COVID syndrome
Beyond the preview
Go deeper on ISRCTN70794078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70794078.